EGFR Clinical Research Trials

Please select a valid location from the dropdown

Filter By

Clear all Advanced

Advanced Filters

Gender
Phase
Study Type
Sponsors
Accepts healthy volunteers
Online Trials
Age Group

Any (13)

Phase 1 (1)
Phase 1/2 (1)
Phase 2 (3)
Phase 2/3 (1)
Phase 3 (3)
Unknown (4)

Interventional (9)
Observational (4)

Hoffmann-La Roche (2)
Sun Yat-sen University (2)
Genzyme, a Sanofi Company (1)
National Cancer Institute, Naples (1)
National Taiwan University Hospital (1)
Second Affiliated Hospital, School of Medicine, Zhejiang University (1)
Shanghai JMT-Bio Inc. (1)
Shanghai Pulmonary Hospital, Shanghai, China (1)
Spectrum Pharmaceuticals, Inc (1)
Universitaire Ziekenhuizen Leuven (1)
Yuhan Corporation (1)

No (13)

No (13)

Adult (18+) (13)

I am/have/had

I am/have/hadnon-squamous non-small cell lung cancer

I am/have/haddepression

I am/have/hadchronic kidney disease

I am/have/hadanticoagulation therapy

I am/have/had12 lead electrocardiogram

I am/have/hadmeasurable disease

I am/have/hadcarcinoma

I am/have/hadanticoagulants

I am/have/hadimmunohistochemistry

I am/have/hadprogrammed cell death 1 ligand 1

I am/have/hadfatigue

I am/have/hadliver metastasis

I am/have/hadsmall cell lung cancer

I am/have/hadEGFR

I am/have/hadplatelet count

I am/have/hadautosomal dominant

I am/have/hadros1

I am/have/hadvegf

I am/have/hadsquamous non-small cell lung cancer

I am/have/hadcurative surgery

added new label for I am/have/had

I am looking for

I am looking foratezolizumab

I am looking forapatinib

I am looking forcabozantinib

I am looking forbevacizumab

I am looking forcisplatin

I am looking forepstein-barr virus dna

I am looking forhepatitis b surface antigen

I am looking forgefitinib

I am looking forgrowth factor

I am looking forangiogenesis inhibitors

I am looking forpd-1 inhibitor

I am looking foranticoagulants

I am looking forlazertinib

I am looking fororal contraceptives

I am looking foraflibercept

I am looking forpyrotinib

I am looking fornimotuzumab

I am looking forhepatitis b core antibody

I am looking forvascular endothelial growth factor

I am looking forvegf

added new label for I am looking for

Advanced Filters

Found 13 clinical trials

For Seniors
For adults
Recruiting in 100s
Observational Study
all
Recruiting

Aflibercept or Bevacizumab as Second-line Treatment of RAS Mutated Metastatic Colorectal Cancer

In this context, the assessment of RAS (N- and K-) oncogene mutations is able to predict the response to anti-EGFR agents being mutated RAS mCRC patients resistant to these drugs. In this group of patients the use of anti-angiogenic drugs (bevacizumab and aflibercept) is predominant.

angiogenesis inhibitors

cancer

folfiri regimen

metastatic colorectal cancer

aflibercept